UBC discovery opens new avenues for designing drugs to combat drug-resistant malaria
Researchers have shown a key difference in the three-dimensional structures of a key metabolic enzyme in the parasite that causes malaria compared to its human counterpart.
UBC-led study finds trial drug can significantly block early stages of COVID-19 in engineered human tissues
The findings hold promise as a treatment capable of stopping early infection of the novel coronavirus.
Scientists discover gene that increases risk of Alzheimer’s disease
International research team led by Dr. Weihong Song has for the first time identified a gene that increases the risk of Alzheimer’s disease.
UBC researchers warn of dangers of air pollution during COVID-19 outbreak
Air pollution can make infections of the respiratory tract more severe.
8% of school-age children have thought about or attempted suicide
A new study looks at risk and protective factors associated with childhood suicide.
Genetic variants place Asians at higher risk of side effects to common medications
A new study by UBC medical student Cody Lo reveals just how serious the side effects can be from commonly prescribed drugs for gout through to depression.
Pilot clinical trial in China to test UBC researcher’s findings as a targeted therapy for COVID-19
APN01, a drug made by Apeiron Biologics and developed based on the work of UBC’s Josef Penninger, is already shown to block viral spread in SARS.
UBC researchers awarded more than $1M to tackle aggressive bone cancer in children
Dr. Mads Daugaard and Dr. Poul Sorensen are employing novel strategies to target Ewing sarcoma.
Peer mentorship programs vital for supporting women leaving prison
New Faculty of Medicine research underscores the value of peer mentorship programs in navigating the transition from prison back into the community.
UBC experts answer coronavirus (COVID-19) questions
Faculty members share their expertise in specialties from pediatrics to psychiatry.